General Information
Revision date
2015-03-23
Product name
Megestrol Acetate Oral Suspension USP, 40 mg/mL
CAS No.
595-33-5
1.2.1 Relevant identified uses
Indicated for the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS)
Emergency telephone
(614) 276-4000
Icons in SDS
Company Information
company name
Boehringer Ingelheim Roxane Inc
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Carcinogenicity Category 1B
Hazard pictograms
None
Signal word
Warning
Hazard statements
This is a pharmaceutical product designed to be prescribed by a licensed health care professional. Should any person while using this product observe any adverse health effects, they should seek medical treatment. May cause cancer
Prevention
Observe good industrial hygiene practices. Do not handle until all safety precautions have been read and understood. Wear protective gloves/protective clothing/eye protection/face protection.
Response
Wash hands after handling. If exposed or concerned: Get medical advice/attention.
Storage
Store at 20 – 25 ºC (68 - 77ºF). Store away from heat. Store away from incompatible materials.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Incineration of waste at an approved USEPA incinerator is recommended. Hazard(s) not otherwise None known.